Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / gentamicin attending: chief complaint: cc: r. knee pain, swelling major surgical or invasive procedure: pacemaker placement central line placement history of present illness: mr. is a 42yo man with history significant for dm1, htn, chf, cri and past history of osteomyelitis of l4-5 presented to on with several days of increasing pain and swelling in the right popliteal fossa without history of trauma. he was referred to the ed from the renal transplant clinic for further evaluation and r/o dvt. he has a known history of right cyst. he had been in his usual state of health with no fevers/chills/nausea/vomiting/or other systemtic symptoms. pt was afebrile without leukocytosis and his pain was controlled with dilaudid. past medical history: past medical history: episode of hyperkalemic bradycardia in with ventricular pacing wire 1. dm1- diagnosed at the age of 25 2. gastroparesis--gastric emptying study at showed 50% emptying at 128 minutes. 3. cri with bl cr 2.9-3.2-- s/p recent admission with worsening rf 4. htn 5. chf with decreased rv function, lvef 65% 4/05 6. anemia 7. nephrolithiasis 8. neuropathy involving his feet b/l 9. s/p facial cellulitis with recent icu admit to 10. s/p l4-5 osteomyelitis from foot ulcer social history: home/marital status: married, lives with wife in . twin 3 yr old daughters. : denies etoh: denies illicits: denies family history: + uncle + father in his mid 50's, +prostate father in mid 50's his brother died in a swimming accident, 1 sister with lupus another sister that was noted to be healthy. denies fhx of lung, colon, thyroid cancer. no leukemia or lymphoma physical exam: vs: tm 99.3 tc 98 bp 142/95 (142-171/81-101) hr 82 (75-84) rr 11 () sat 99% ra (96-99%). gen: pleasant man in nad, sitting up in chair. heent: mmm, nc/at, sclerae anicteric. neck: no masses, thyroid non-palpable. jvp ~10cm cv: normal s1/s2, rrr. pul: bibasilar crackles. abd: soft, nd. +bs. mild tenderness luq. ext: no edema. 2+ dp b/l. 2+ rp b/l. skin: no rashes, dry skin on shins. neuro: a&ox3. pertinent results: 10:07pm glucose-407* urea n-95* creat-3.9* sodium-137 potassium-5.6* chloride-106 total co2-18* anion gap-19 10:07pm wbc-8.6 rbc-3.18* hgb-7.9* hct-27.3* mcv-86 mch-24.8* mchc-28.9* rdw-17.6* rle u/s: no evidence of right lower extremity deep vein thrombosis. right-sided cyst. mri knee: radial tear of the lateral meniscus. moderate effusion with nonspecific synovitis. small cyst, with edema suggesting possible rupture. mri abdomen w/o & w/contrast 11:55 pm: 1. no renal artery stenosis. there is diminished renal cortical medullary differentiation, consistent with medical renal disease. 2. third spacing of fluid within the soft tissues is noted. 09:30am blood wbc-8.1 rbc-3.36* hgb-8.9* hct-27.4* mcv-82 mch-26.6* mchc-32.5 rdw-17.5* plt ct-364 09:30am blood glucose-112* urean-89* creat-4.0* na-141 k-3.9 cl-107 hco3-22 angap-16 04:00am blood ck-mb-notdone ctropnt-0.37* 09:30am blood calcium-8.7 phos-6.2* mg-2.3 11:15am blood pth-107* 04:05pm blood hapto-257* 12:41am blood tsh-5.5* 05:20am blood vanco-16.7* discharge labs: 09:30am blood wbc-8.1 rbc-3.36* hgb-8.9* hct-27.4* mcv-82 mch-26.6* mchc-32.5 rdw-17.5* plt ct-364 09:30am blood plt ct-364 09:30am blood glucose-112* urean-89* creat-4.0* na-141 k-3.9 cl-107 hco3-22 angap-16 09:30am blood calcium-8.7 phos-6.2* mg-2.3 brief hospital course: on , overnight following admission, the pt developed bradycardia, hypotension and decreased mental status. code blue was called, ekg showed bradycardia with hr 31. pt responded to transcutaneous pacing and dopamine. pt's sbp returned to 160 and hr came up. abg was 7.17/43/220/17, novolyte potassium was 6.4. was given bicarb for acidemia and transferred to ccu. in ccu was given calcium gluconate, insulin, d50 bolus, d5w with 150 meq bicarb drip at 100cc/hr and kayexalate. renal was consulted. albuterol was also added to lower k. potassium improved to 5.7 then 5.0. repeat abg done 7.23/44/104/19. ck was found to be 88 and troponin slightly elevated at 0.34. in the ccu, once he was stabilized, it was determined that he would have a pacemaker placed. because of his portacath, used for frequent blood draws and lasix infusions, surgery was consulted for removal, however given that it was not infected, ep placed pacemaker on right side of chest, uneventfully. for his renal issues, his cri likely due to diabetic nephropathy. pt's baseline cr recently has been 3.2-4.3. he episode of hyperkalemia secondary to renal insufficiency and diuresis. his primary nephrologist, dr. did not feel that hemodialysis was indicated. mra of renal arteries was normal. he has eosinophilia and muddy brown casts, suggestive of mild atn. he is also undergoing an outpatient transplant eval. we followed his potassium and fluid balance carefully, and titrated his lasix to 120mg po qd with zaroxolyn to augment his diuresis. for his cyst, he had been suffering from knee pain for some time and the presence of cyst was diagnosed a month earlier. vanco started because of the accompanying erythema and rheumatology consulted. an arthrocentesis was performed with steroid injection which revealed non-infectious fluid. subsequent cultures were sterile. an mri performed showeed a meniscal tear. orthopedics recommended conservative therapy with ice/pain control for cyst. nsaids were contraindicated given his renal insufficiencey. for his type i diabetes mellitus, we continued sliding-scale insulin and fingerstick checks four times, daily. for his anemia, we felt this was secondary to his chronic renal insufficiency, a result of decreased erythropoesis. his epogen was continued, per renal recs. for f/e/n, we continued diabetic, low sodium diet for prophylaxis, he was kept on a ppi, and per request from renal, we held his heparin given that they found reports that it could worsen hyperkalemia. for access, we accessed his portacath, as well as peripheral ivs. his code status was full. medications on admission: aspirin 81 mg qd folic acid 1 mg qd simvastatin 10mg qd venlafaxine 75 mg protonix 40 mg qd fluoxetine 20 qd sevelamer 800 mg tid acetaminophen 1g q6hrs b complex-vitamin c-folic acid 1 mg qd metoprolol tartrate 50 mg gabapentin 300 mg qd epoetin alfa 10,000u qmo/we/fr levothyroxine sodium 75 mcg qd sodium citrate-citric acid 15mg qd bumex 3 isosorbide mononitrate 30 mg sr qd hydralazine 25 mg q6h clonidine 0.1 mg metolazone 5mg insulin lantus 6 units qam + riss ferrous sulfate 325 tid discharge medications: 1. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po daily (daily). 2. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 3. sevelamer 800 mg tablet sig: two (2) tablet po tid (3 times a day). :*180 tablet(s)* refills:*2* 4. furosemide 80 mg tablet sig: 1.5 tablets po bid (2 times a day). :*90 tablet(s)* refills:*2* 5. metolazone 2.5 mg tablet sig: one (1) tablet po daily (daily). :*30 tablet(s)* refills:*2* 6. oxycodone 5 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed. :*60 tablet(s)* refills:*0* 7. venlafaxine 75 mg tablet sig: one (1) tablet po bid (2 times a day). :*60 tablet(s)* refills:*2* 8. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). :*30 tablet, delayed release (e.c.)(s)* refills:*2* 9. fluoxetine 20 mg capsule sig: one (1) capsule po daily (daily). :*30 capsule(s)* refills:*2* 10. levothyroxine sodium 75 mcg tablet sig: one (1) tablet po daily (daily). :*30 tablet(s)* refills:*2* 11. epoetin alfa 10,000 unit/ml solution sig: 10,000 units injection qmowefr (monday -wednesday-friday). 12. aluminum hydroxide gel 600 mg/5 ml suspension sig: thirty (30) ml po tid (3 times a day). 13. clonidine 0.1 mg tablet sig: one (1) tablet po bid (2 times a day). 14. isosorbide dinitrate 10 mg tablet sig: one (1) tablet po tid (3 times a day). :*90 tablet(s)* refills:*2* 15. metoclopramide 10 mg tablet sig: 0.5 tablet po qidachs (4 times a day (before meals and at bedtime)). :*60 tablet(s)* refills:*2* 16. simvastatin 40 mg tablet sig: 0.5 (one half) tablet po once a day. :*15 tablet(s)* refills:*2* 17. amlodipine 10 mg tablet sig: one (1) tablet po once a day. :*30 tablet(s)* refills:*2* 18. hydralazine 25 mg tablet sig: one (1) tablet po q8h (every 8 hours). :*90 tablet(s)* refills:*2* 19. metoprolol succinate 25 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). :*30 tablet sustained release 24hr(s)* refills:*2* 20. insulin glargine 100 unit/ml solution sig: four (4) units subcutaneous at bedtime. :*1 month supply* refills:*2* 21. insulin regular human 100 unit/ml solution sig: as directed injection four times a day: per sliding scale: fsbg 150-200 2units, 201-250 4 units; 251-300 6 units; 301-350 8 u' 351-400 10u; if greater than 400u call your pcp. :*1 month supply* refills:*2* 22. syringe (disposable) 1 ml syringe sig: one (1) syringe miscell. once a day: for 1cc (10,000u) epogen injections. :*100 syringes* refills:*2* 23. clindamycin hcl 150 mg capsule sig: one (1) capsule po q6h (every 6 hours) for 2 days. :*8 capsule(s)* refills:*0* discharge disposition: home with service facility: discharge diagnosis: renal failure right knee meniscal tear cyst cardiac arrest congestive heart failure type i diabetes mellitus chronic renal insufficiency discharge condition: stable, afebrile. discharge instructions: please seek medical attention for fevers>101.4, for chest pain, or for anything else medically concerning. please take your medications as directed. please check your weight daily. please call dr. if your daily weights begin to rise. please continue clindamycin for 2 days. followup instructions: 1) please see dr. /orthopedics within wks 2) please see your pcp 1 week for follow up. 3) provider: clinic where: cardiac services phone: date/time: 10:00 4) provider: , md where: lm center phone: date/time: 1:00 5) provider: , md where: lm center phone: date/time: 1:00 md procedure: injection of steroid initial insertion of dual-chamber device initial insertion of transvenous leads [electrodes] into atrium and ventricle arthrocentesis injection of therapeutic substance into joint or ligament diagnoses: acidosis hyperpotassemia anemia in chronic kidney disease congestive heart failure, unspecified acute kidney failure, unspecified polyneuropathy in diabetes hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other specified cardiac dysrhythmias other specified hypotension diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis synovial cyst of popliteal space 

Answer: The patient is high likely exposed to